Literature DB >> 26831435

Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer.

Nirmanmoh Bhatia1, Marilia Santos1, Lee W Jones1, Joshua A Beckman1, David F Penson1, Alicia K Morgans2, Javid Moslehi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26831435      PMCID： PMC5029929          DOI： 10.1161/CIRCULATIONAHA.115.012519

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  Exercise as treatment for androgen deprivation therapy-associated physical dysfunction: ready for prime time?

Authors:  Michael R Harrison; Lee W Jones
Journal:  Eur Urol       Date:  2013-12-02       Impact factor: 20.096

2.  ABCDE steps to prevent heart disease in breast cancer survivors.

Authors:  Kamaneh Montazeri; Christine Unitt; JoAnne M Foody; Jay R Harris; Ann H Partridge; Javid Moslehi
Journal:  Circulation       Date:  2014-10-28       Impact factor: 29.690

3.  Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.

Authors:  Glenn N Levine; Anthony V D'Amico; Peter Berger; Peter E Clark; Robert H Eckel; Nancy L Keating; Richard V Milani; Arthur I Sagalowsky; Matthew R Smith; Neil Zakai
Journal:  Circulation       Date:  2010-02-01       Impact factor: 29.690

Review 4.  The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy.

Authors:  Vincenza Conteduca; Giuseppe Di Lorenzo; Alfredo Tartarone; Michele Aieta
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

5.  Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist.

Authors:  Peter C Albertsen; Laurence Klotz; Bertrand Tombal; James Grady; Tine K Olesen; Jan Nilsson
Journal:  Eur Urol       Date:  2013-11-01       Impact factor: 20.096

Review 6.  State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease.

Authors:  Beth E Cohen; Donald Edmondson; Ian M Kronish
Journal:  Am J Hypertens       Date:  2015-04-24       Impact factor: 2.689

Review 7.  Adverse effects of androgen deprivation therapy and strategies to mitigate them.

Authors:  Paul L Nguyen; Shabbir M H Alibhai; Shehzad Basaria; Anthony V D'Amico; Philip W Kantoff; Nancy L Keating; David F Penson; Derek J Rosario; Bertrand Tombal; Matthew R Smith
Journal:  Eur Urol       Date:  2014-08-02       Impact factor: 20.096

8.  Temporal trends in cause of death among Swedish and US men with prostate cancer.

Authors:  Mara M Epstein; Gustaf Edgren; Jennifer R Rider; Lorelei A Mucci; Hans-Olov Adami
Journal:  J Natl Cancer Inst       Date:  2012-07-25       Impact factor: 13.506

9.  The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona.

Authors:  Cristiane Murta-Nascimento; Ana Isabel Romero; Maria Sala; José Antonio Lorente; Joaquim Bellmunt; Núria Juanpere Rodero; Josep Lloreta; Àngels Hospital; Andrea Burón; Xavier Castells; Francesc Macià
Journal:  Eur J Cancer Prev       Date:  2015-07       Impact factor: 2.497

10.  Androgen deprivation therapy reversibly increases endothelium-dependent vasodilation in men with prostate cancer.

Authors:  Paul L Nguyen; Petr Jarolim; Shehzad Basaria; Jonah P Zuflacht; Jessica Milian; Samoneh Kadivar; Powell L Graham; Andrew Hyatt; Philip W Kantoff; Joshua A Beckman
Journal:  J Am Heart Assoc       Date:  2015-04-20       Impact factor: 5.501
View more
  38 in total

1.  Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities.

Authors:  Grace Lu-Yao; Nikita Nikita; Scott W Keith; Ginah Nightingale; Krupa Gandhi; Sarah E Hegarty; Timothy R Rebbeck; Andrew Chapman; Philip W Kantoff; Jennifer Cullen; Leonard Gomella; William Kevin Kelly
Journal:  Eur Urol       Date:  2019-08-13       Impact factor: 20.096

Review 2.  Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer.

Authors:  Megha Agarwal; Timothy Canan; Greg Glover; Nidhi Thareja; Andre Akhondi; Joshua Rosenberg
Journal:  Curr Oncol Rep       Date:  2019-08-24       Impact factor: 5.075

Review 3.  Strategies to Prevent Cardiotoxicity.

Authors:  Jason Graffagnino; Lavanya Kondapalli; Garima Arora; Riem Hawi; Carrie G Lenneman
Journal:  Curr Treat Options Oncol       Date:  2020-04-08

4.  Pharmacogenomics for immunotherapy and immune-related cardiotoxicity.

Authors:  Jessica A Castrillon; Charis Eng; Feixiong Cheng
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

Review 5.  Cardiovascular Risk in Survivors of Cancer.

Authors:  Henry Chen Zheng; Laura Onderko; Sanjeev A Francis
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

Review 6.  Cancer and Coronary Artery Disease: Common Associations, Diagnosis and Management Challenges.

Authors:  Debashish Das; Alex Asher; Arjun K Ghosh
Journal:  Curr Treat Options Oncol       Date:  2019-05-06

7.  Trends in Obesity Prevalence in Adults With a History of Cancer: Results From the US National Health Interview Survey, 1997 to 2014.

Authors:  Heather Greenlee; Zaixing Shi; Christine L Sardo Molmenti; Andrew Rundle; Wei Yann Tsai
Journal:  J Clin Oncol       Date:  2016-07-25       Impact factor: 44.544

Review 8.  Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses.

Authors:  Jiun-Ruey Hu; Meredith S Duncan; Alicia K Morgans; Jonathan D Brown; Wouter C Meijers; Matthew S Freiberg; Joe-Elie Salem; Joshua A Beckman; Javid J Moslehi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-01-23       Impact factor: 8.311

Review 9.  Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients.

Authors:  Sakthivel Muniyan; Lei Xi; Kaustubh Datta; Anindita Das; Benjamin A Teply; Surinder K Batra; Rakesh C Kukreja
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-06-11       Impact factor: 10.680

10.  Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.

Authors:  G Curigliano; D Lenihan; M Fradley; S Ganatra; A Barac; A Blaes; J Herrmann; C Porter; A R Lyon; P Lancellotti; A Patel; J DeCara; J Mitchell; E Harrison; J Moslehi; R Witteles; M G Calabro; R Orecchia; E de Azambuja; J L Zamorano; R Krone; Z Iakobishvili; J Carver; S Armenian; B Ky; D Cardinale; C M Cipolla; S Dent; K Jordan
Journal:  Ann Oncol       Date:  2020-02       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.